Patient recruitment remains a significant challenge for biopharma companies, often leading to delays and increased costs in clinical trials. Traditional recruitment methods can be time-consuming ...

It comes as no surprise that more than 80% of clinical trials in the U.S fail to meet their patient enrolment times. The Patient Recruitment for Rare Disease Trials Summit addresses these ...

By providing real-time patient identification and continuous relevant data monitoring, the solution reduces recruitment bottlenecks, enhances trial efficiency, and helps bring life-saving ...